Log in
NASDAQ:NTLA

Intellia Therapeutics Options Chain and Prices

$23.51
+1.06 (+4.72 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$22.85
Now: $23.51▼
$23.90
50-Day Range
$17.47
MA: $19.90▼
$22.97
52-Week Range
$9.18
Now: $23.51▼
$25.56
Volume2.46 million shs
Average Volume835,916 shs
Market Capitalization$1.38 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.69

Options Chain

Intellia Therapeutics (NASDAQ:NTLA) Options Chain

 $ 
ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades
10/16/2020$35.00$0.000Call00032
(+0)		0.00
10/16/2020$30.00$0.500Call101154
(+0)		0.8588860.1825941
10/16/2020$25.00$1.275Call65605701
(+212)		0.721015
(-0.050543)		0.41779713
10/16/2020$22.50$2.400Call1510144
(+0)		0.729344
(+0.084667)		0.6250234
10/16/2020$20.00$4.250Call100312
(+0)		0.847943
(-0.209287)		0.7899341
10/16/2020$17.50$0.000Call000150
(+0)		0.00
10/16/2020$15.00$0.000Call550133
(+0)		0.9574870.01
10/16/2020$12.50$0.000Call00063
(+0)		0.00
10/16/2020$10.00$13.000Call55088
(+0)		0.01.01
10/16/2020$7.50$0.000Call00014
(+0)		0.00
10/16/2020$5.00$0.000Call0000
(+0)		0.00
10/16/2020$2.50$0.000Call0000
(+0)		0.00
10/16/2020$35.00$0.000Put0000
(+0)		0.00
10/16/2020$30.00$0.000Put0000
(+0)		0.00
10/16/2020$25.00$0.000Put1103
(+0)		0.7839210.01
10/16/2020$22.50$0.000Put55042
(+0)		0.867264
(+0.018559)		0.01
10/16/2020$20.00$0.000Put1020101182
(+0)		1.09458
(-0.330906)		0.03
10/16/2020$17.50$0.675Put210122
(+0)		1.18586
(+0.276237)		-0.1437232
10/16/2020$15.00$0.550Put000449
(+0)		1.51302
(+0.129723)		-0.0976630
10/16/2020$12.50$0.525Put101161
(+0)		1.93851
(+0.114325)		-0.0731671
10/16/2020$10.00$0.000Put000143
(+0)		0.00
10/16/2020$7.50$0.000Put0004
(+0)		0.00
10/16/2020$5.00$0.000Put0000
(+0)		0.00
10/16/2020$2.50$0.000Put0000
(+0)		0.00
End-of-day options data provided by Trade Alert and Intrinio.
This page was last updated on 9/19/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.